Research progress of the relationship between phosphoprotein phosphatases (PPPs) and neurodevelopmental disorders

Wenya Ji1, Bixia Zheng1, Aihua Zhang2

  • 1Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China.

Clinical Genetics
|September 20, 2024
PubMed

Insights

Protein phosphatases (PPPs) are crucial for brain development, and gene variants are linked to neurodevelopmental disorders. Current treatments are symptomatic, highlighting the need for further research into therapeutic targets and novel gene discovery.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • Reversible protein phosphorylation is vital for eukaryotic cellular functions.
  • Protein phosphatases (PPPs) play a key role in neurodevelopment.
  • Genetic variants in PPP family members are associated with neurodevelopmental disorders.

Purpose of the Study:

  • To provide a comprehensive overview of clinical phenotypes, genotypes, and pathogenic mechanisms in patients with PPP gene variants.
  • To identify challenges in genotype-phenotype correlation analysis and prognostic counseling.
  • To explore potential future research directions and therapeutic targets.

Main Methods:

  • Comprehensive review of clinical phenotypes, genotypes, and pathogenic mechanisms.
  • Analysis of existing literature on PPP gene variants and neurodevelopmental disorders.
  • Identification of challenges in current research methodologies and data availability.

Main Results:

  • Variants in 10 coding genes across four PPP family members are implicated in neurodevelopmental disorders.
  • Inconsistent clinical descriptions and lack of large multicenter studies hinder genotype-phenotype correlation.
  • Scarcity of follow-up data impedes prognostic counseling for rare diseases.

Conclusions:

  • Symptomatic treatments are currently the standard for affected patients.
  • Protein phosphatase regulators represent potential therapeutic targets.
  • Further research should investigate other protein phosphatase family members and undiscovered variants, utilizing spatial-temporal protein data and animal models for gene discovery.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.1K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495